Literature DB >> 16044014

Predominance of a rare type of HIV-1 in Estonia.

Maarja Adojaan1, Toomas Kivisild, Andres Männik, Tõnu Krispin, Valentina Ustina, Kai Zilmer, Elo Liebert, Nikolai Jaroslavtsev, Ludmilla Priimägi, Valentina Tefanova, Jelena Schmidt, Kai Krohn, Richard Villems, Mika Salminen, Mart Ustav.   

Abstract

An earlier study has indicated that a complex recombinant HIV-1 strain dominates the epidemic in Estonia. The objective of this study was to further investigate the molecular epidemiology and genetic structure of HIV-1 in Estonia. Most of the investigated individuals became infected after August 2000 when HIV-1 started to spread rapidly among Estonian intravenous drug users (IDUs). Two viral DNA regions, gag/pol and gp41, were sequenced and subtyped from peripheral blood mononuclear cells or plasma from 141 individuals. Phylogenetic analysis in the gp41 region revealed that the most frequent type of the virus among IDUs was a circulating recombinant form, CRF06_cpx, whereas a few samples showed highest sequence similarity to a subtype A strain circulating in Ukraine and Russia. Likewise, in the gag/pol region, most of the samples were classified as CRF06_cpx, with a few classified as subtype A. In this region, however, 16% of the sequences turned out to be mosaic unique recombinant forms consisting of CRF06_cpx and subtype A. At least 9 mosaic forms were identified, each with distinct patterns of multiple crossover. To characterize Estonian CRF06_cpx as well as recombinant isolates in more detail, 4 near-full-length HIV-1 genomes were sequenced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044014

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  14 in total

1.  Estonia at the threshold of the fourth decade of the AIDS era in Europe.

Authors:  Kaja-Triin Laisaar; Radko Avi; Jack DeHovitz; Anneli Uusküla
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-11       Impact factor: 2.205

2.  HIV diversity, molecular epidemiology, and the role of recombination.

Authors:  Gustavo H Kijak; Francine E McCutchan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

3.  Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.

Authors:  Hiromi Imamichi; Ousmane Koita; Djeneba Dabitao; Sounkalo Dao; Mahamadou Ibrah; Dramane Sogoba; Robin L Dewar; Steve C Berg; Min-Kang Jiang; Mark Parta; Janice A Washington; Michael A Polis; H Clifford Lane; Anatole Tounkara
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

4.  Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010.

Authors:  Radko Avi; Kristi Huik; Merit Pauskar; Valentina Ustina; Tõnis Karki; Eveli Kallas; Ene-Ly Jõgeda; Tõnu Krispin; Irja Lutsar
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-05       Impact factor: 2.205

5.  StepBrothers: inferring partially shared ancestries among recombinant viral sequences.

Authors:  Erik W Bloomquist; Karin S Dorman; Marc A Suchard
Journal:  Biostatistics       Date:  2008-06-18       Impact factor: 5.899

6.  Multiple HIV-1 introductions into the Swedish intravenous drug user population.

Authors:  Helena Skar; Staffan Sylvan; Hans-Bertil Hansson; Olle Gustavsson; Hans Boman; Jan Albert; Thomas Leitner
Journal:  Infect Genet Evol       Date:  2008-04-08       Impact factor: 3.342

7.  Distinct HIV type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania.

Authors:  Saulius Caplinskas; Vladimir V Loukachov; Elena L Gasich; Alla V Gilyazova; Irma Caplinskiene; Vladimir V Lukashov
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-01       Impact factor: 2.205

8.  A uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in Russian subtype A HIV-1 viruses.

Authors:  Anna N Kolomeets; Vici Varghese; Philippe Lemey; Marina R Bobkova; Robert W Shafer
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

9.  CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.

Authors:  Kristi Huik; Maarja Sadam; Tõnis Karki; Radko Avi; Tõnu Krispin; Piret Paap; Kristi Rüütel; Anneli Uusküla; Ave Talu; Katri Abel-Ollo; Irja Lutsar
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

Review 10.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.